Picard Medical, Inc.
PMI
$0.46
-$0.02-3.93%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.69% | 34.73% | 206.05% | -68.69% | 1.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.69% | 34.73% | 206.05% | -68.69% | 1.21% |
| Cost of Revenue | -14.57% | -15.25% | 109.20% | -16.62% | -63.86% |
| Gross Profit | 202.21% | 80.68% | 66.75% | -144.36% | 112.24% |
| SG&A Expenses | -1.78% | -14.38% | 5.96% | 4.58% | -30.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.98% | -12.23% | 24.94% | 0.36% | -34.56% |
| Operating Income | 15.93% | 21.53% | 7.92% | -73.40% | 39.56% |
| Income Before Tax | 51.58% | -68.00% | -65.74% | -183.01% | -47.70% |
| Income Tax Expenses | 126.67% | -- | -- | -- | -650.00% |
| Earnings from Continuing Operations | 51.45% | -68.00% | -65.74% | -184.60% | -47.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.45% | -68.00% | -65.74% | -184.60% | -47.50% |
| EBIT | 15.93% | 21.53% | 7.92% | -73.40% | 39.56% |
| EBITDA | 16.06% | 21.72% | 8.97% | -85.20% | 38.78% |
| EPS Basic | 95.14% | 77.92% | -13.41% | -141.60% | -43.18% |
| Normalized Basic EPS | 93.54% | 75.49% | -49.28% | -182.37% | -47.71% |
| EPS Diluted | 95.14% | 77.92% | -13.41% | -141.60% | -43.18% |
| Normalized Diluted EPS | 93.54% | 75.49% | -49.28% | -182.37% | -47.71% |
| Average Basic Shares Outstanding | 827.77% | 585.48% | 11.02% | 0.25% | 0.01% |
| Average Diluted Shares Outstanding | 827.77% | 585.48% | 11.02% | 0.25% | 0.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |